SCHEMBL514274

SCHEMBL514274

[CH2]S(=O)(=O)c1ccc(I)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 7/20 0.50
CA2 P00918 7/20 0.50
MMP2 P08253 2/20 0.50
MMP9 P14780 2/20 0.50
MMP1 P03956 1/20 0.50
MMP8 P22894 1/20 0.50
MMP13 P45452 1/20 0.50
F2 P00734 3/20 0.45
PRSS1 P07477 3/20 0.45
PRSS2 P07478 3/20 0.45
PRSS3 P35030 3/20 0.45
RAPGEF4 Q8WZA2 1/20 0.42
CA9 Q16790 2/20 0.39
CA12 O43570 1/20 0.39
SIGMAR1 Q99720 4/20 0.36
TPMT P51580 1/20 0.35
ITGA1 P56199 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
RAD51 Q06609 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL896933 0.77 RAPGEF4 (0.56) CA1CA2MMP2MMP9MMP1
SCHEMBL9745386 0.74 CA1 (0.52) CA1CA2MMP2MMP9MMP1
SCHEMBL3292709 0.74 CA1 (0.52) CA1CA2MMP2MMP9MMP1
SCHEMBL5075906 0.72 CA1 (0.50) CA1CA2MMP2MMP9MMP1
SCHEMBL444871 0.72 MMP2 (0.50) CA1CA2MMP2MMP9MMP1
SCHEMBL6103050 0.72 CA1 (0.50) CA1CA2MMP2MMP9MMP1
SCHEMBL1008930 0.72 CA2 (0.64) CA1CA2CA9CA12
SCHEMBL6918559 0.72 CA1 (0.50) CA1CA2MMP2MMP9MMP1
SCHEMBL155902 0.72 ALDH1A1 (0.55) CA1CA2MMP2MMP9MMP1
SCHEMBL514614 0.72 GAA (0.62) CA1CA2MMP2MMP9MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023210623-A1 HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME 株式会社エス・ディー・エス バイオテック 2023-11-02 WO disclosed
WO-2014184071-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 WO disclosed
WO-2014184070-A1 MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES SYNGENTA LIMITED (GB) 2014-11-20 WO disclosed
EP-2420493-A1 HALOALKYLSULFONANILIDE DERIVATIVE Nissan Chemical Industries, Ltd. (JP) 2012-02-22 EP disclosed
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-02-02 US disclosed
EP-2336104-A1 ORTHO-SUBSTITUTED HALOALKYLSULFONANILIDE DERIVATIVE AND HERBICIDE Nissan Chemical Industries, Ltd. (JP) 2011-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029187-A1 HALOALKYLSULFONANILIDE DERIVATIVE CBR3, CBR1, HDHD5 CA1 1364/4885CA2 200/4885MMP2 3744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.